Literature DB >> 16648474

Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth.

Qinghang Liu1, Benjamin J Wilkins, Yong J Lee, Hidenori Ichijo, Jeffery D Molkentin.   

Abstract

The calcium-calmodulin-activated protein phosphatase calcineurin functions as a key mediator of diverse biologic processes, including differentiation, apoptosis, growth, and adaptive responses, in part through dephosphorylation and activation of nuclear factor of activated T-cell (NFAT) transcription factors. Apoptosis signal-regulating kinase 1 (ASK1) is an upstream component of the mitogen-activated protein kinases that serves as a pivotal regulator of cytokine-, oxidative-, and stress-induced cell death. Here, we performed a yeast two-hybrid screen with calcineurin B as bait, which identified ASK1 as a direct physical interacting partner. The C-terminal 218 amino acids of ASK1 were sufficient to mediate interaction with calcineurin B in yeast, as well as in mammalian cell lysates. Importantly, endogenous calcium binding B subunit (CnB) protein interacted with endogenous ASK1 protein in cardiomyocytes at baseline, suggesting that the interaction observed in yeast was of potential biologic relevance. Indeed, calcineurin directly dephosphorylated ASK1 at serine 967 using purified proteins or mammalian cell lysates. Dephosphorylation of ASK1 serine 967 by calcineurin promoted its disassociation from 14-3-3 proteins, resulting in ASK1 activation. Calcineurin and ASK1 cooperatively enhanced cardiomyocyte apoptosis, while expression of a dominant negative ASK1 blocked calcineurin-induced apoptosis. Mouse embryonic fibroblasts deficient in ask1 were also partially resistant to calcineurin- or ionomycin-induced apoptosis. Finally, ASK1 negatively regulated calcineurin-NFAT signaling indirectly through c-Jun NH2-terminal kinase (JNK)- and p38-mediated phosphorylation of NFAT, which blocked calcineurin- and agonist-dependent hypertrophic growth of cardiomyocytes. Thus, ASK1 and calcineurin-NFAT constitute a feedback regulatory circuit in which calcineurin positively regulates ASK1 through direct dephosphorylation, while ASK1 negatively regulates calcineurin-NFAT signaling through p38- and JNK-mediated NFAT phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648474      PMCID: PMC1489013          DOI: 10.1128/MCB.26.10.3785-3797.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

Review 1.  NFAT signaling: choreographing the social lives of cells.

Authors:  Gerald R Crabtree; Eric N Olson
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  The cell cycle-regulatory CDC25A phosphatase inhibits apoptosis signal-regulating kinase 1.

Authors:  X Zou; T Tsutsui; D Ray; J F Blomquist; H Ichijo; D S Ucker; H Kiyokawa
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

3.  Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress.

Authors:  K Morita; M Saitoh; K Tobiume; H Matsuura; S Enomoto; H Nishitoh; H Ichijo
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

4.  Apoptosis signal-regulating kinase 1 is involved not only in apoptosis but also in non-apoptotic cardiomyocyte death.

Authors:  Tetsuya Watanabe; Kinya Otsu; Toshihiro Takeda; Osamu Yamaguchi; Shungo Hikoso; Kazunori Kashiwase; Yoshiharu Higuchi; Masayuki Taniike; Atsuko Nakai; Yasushi Matsumura; Kazuhiko Nishida; Hidenori Ichijo; Masatsugu Hori
Journal:  Biochem Biophys Res Commun       Date:  2005-07-29       Impact factor: 3.575

5.  Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy.

Authors:  Shinichi Hirotani; Kinya Otsu; Kazuhiko Nishida; Yoshiharu Higuchi; Takashi Morita; Hiroyuki Nakayama; Osamu Yamaguchi; Toshiaki Mano; Yasushi Matsumura; Hikaru Ueno; Michihiko Tada; Masatsugu Hori
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

6.  Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism.

Authors:  J Chen; K Fujii; L Zhang; T Roberts; H Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

Review 7.  Calcineurin and cardiac hypertrophy: where have we been? Where are we going?

Authors:  Benjamin J Wilkins; Jeffery D Molkentin
Journal:  J Physiol       Date:  2002-05-15       Impact factor: 5.182

8.  Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer.

Authors:  Kei Tobiume; Masao Saitoh; Hidenori Ichijo
Journal:  J Cell Physiol       Date:  2002-04       Impact factor: 6.384

9.  The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes.

Authors:  Q Liang; R J Wiese; O F Bueno; Y S Dai; B E Markham; J D Molkentin
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  Activity-dependent nuclear translocation and intranuclear distribution of NFATc in adult skeletal muscle fibers.

Authors:  Y Liu; Z Cseresnyés; W R Randall; M F Schneider
Journal:  J Cell Biol       Date:  2001-10-01       Impact factor: 10.539

View more
  43 in total

1.  Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling.

Authors:  Qinghang Liu; Yi Chen; Mannix Auger-Messier; Jeffery D Molkentin
Journal:  Circ Res       Date:  2012-03-08       Impact factor: 17.367

Review 2.  Novel Ser/Thr protein phosphatases in cell death regulation.

Authors:  Haipeng Sun; Yibin Wang
Journal:  Physiology (Bethesda)       Date:  2012-02

3.  Subcellular Localization and Activity of the Mitogen-Activated Protein Kinase Kinase 7 (MKK7) γ Isoform are Regulated through Binding to the Phosphatase Calcineurin.

Authors:  Emily S Gibson; Kevin M Woolfrey; Huiming Li; Patrick G Hogan; Raphael A Nemenoff; Lynn E Heasley; Mark L Dell'Acqua
Journal:  Mol Pharmacol       Date:  2018-11-07       Impact factor: 4.436

4.  Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy.

Authors:  Dao-Fu Dai; Tony Chen; Hazel Szeto; Madeline Nieves-Cintrón; Vassily Kutyavin; Luis F Santana; Peter S Rabinovitch
Journal:  J Am Coll Cardiol       Date:  2011-05-27       Impact factor: 24.094

5.  miR-155 functions downstream of angiotensin II receptor subtype 1 and calcineurin to regulate cardiac hypertrophy.

Authors:  Yong Yang; Yong Zhou; Zheng Cao; Xin Zhu Tong; Hua Qiang Xie; Tao Luo; Xian Ping Hua; Han Qin Wang
Journal:  Exp Ther Med       Date:  2016-07-05       Impact factor: 2.447

Review 6.  Calcineurin-AKAP interactions: therapeutic targeting of a pleiotropic enzyme with a little help from its friends.

Authors:  Moriah Gildart; Michael S Kapiloff; Kimberly L Dodge-Kafka
Journal:  J Physiol       Date:  2018-12-26       Impact factor: 5.182

7.  CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.

Authors:  Scott M MacDonnell; Jutta Weisser-Thomas; Hajime Kubo; Marie Hanscome; Qinghang Liu; Naser Jaleel; Remus Berretta; Xiongwen Chen; Joan H Brown; Abdel-Karim Sabri; Jeffery D Molkentin; Steven R Houser
Journal:  Circ Res       Date:  2009-07-16       Impact factor: 17.367

8.  Serine-threonine kinase receptor-associated protein inhibits apoptosis signal-regulating kinase 1 function through direct interaction.

Authors:  Haiyoung Jung; Hyun-A Seong; Ravi Manoharan; Hyunjung Ha
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

Review 9.  Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure.

Authors:  Larissa Lipskaia; Elie R Chemaly; Lahouaria Hadri; Anne-Marie Lompre; Roger J Hajjar
Journal:  Expert Opin Biol Ther       Date:  2010-01       Impact factor: 4.388

10.  Elevating calcium in Th2 cells activates multiple pathways to induce IL-4 transcription and mRNA stabilization.

Authors:  Liying Guo; Joseph F Urban; Jinfang Zhu; William E Paul
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.